The Medicare Advantage landscape has entered a defining year, with CMS fully calculating risk scores using the 2024 CMS-HCC V28 model starting January 2026 and ramping up quarterly RADV audit enforcement across all eligible contracts.
For health plans and providers, accurately tracking member health status has never been more consequential, since missed chronic conditions can cost thousands of dollars per member each year while unsupported diagnoses can trigger multimillion-dollar False Claims Act exposure.
Modern risk adjustment software replaces manual chart reviews and fragmented coding with AI-driven workflows that capture diagnoses, validate clinical evidence, and build audit-ready documentation at scale.
Below are the five platforms leading this transformation in 2026, each offering distinct strengths for organizations that want to track population health status with precision, speed, and defensibility.
Each solution highlighted here has been evaluated on coding accuracy, audit readiness, lifecycle coverage, and the ability to turn scattered medical record data into a governed, auditable view of member health status.
Use this list as a starting framework and then validate each platform against your own population size, existing infrastructure, and compliance priorities before making a final purchasing decision.
1. RAAPID: Neuro-Symbolic AI for End-to-End Risk Adjustment
RAAPID is a leading risk adjustment software in 2026, powered by its proprietary Neuro-Symbolic AI engine that combines neural network pattern recognition with a clinical knowledge graph containing millions of entity relationships.
Rather than relying on surface-level keyword matching like conventional NLP platforms, RAAPID reads, reasons, and defends every suggested HCC code with traceable MEAT evidence drawn directly from the source documentation.
The platform achieves 92% out-of-the-box HCC coding accuracy, rising to 98% with final coder validation, while processing charts in under 8 minutes per chart compared with the 40-plus-minute industry average that still dominates legacy operations.
Health plans using RAAPID have reported returns of up to 10:1 ROI and $2,000–$4,000 in additional revenue captured per member, making it a strong fit for organizations preparing for intensified RADV cycles and V28 implementation pressure.
Backed by a Series A from M12 (Microsoft’s venture fund), HITRUST-certified, and Microsoft Healthcare AI Certified, RAAPID meets rigorous standards for clinical relevance, data privacy, and responsible AI in healthcare.
What sets RAAPID apart is its end-to-end lifecycle coverage across prospective pre-visit planning, point-of-care delivery, and retrospective chart review inside a single unified platform, eliminating the multi-vendor complexity that typically drags down risk adjustment programs.
For Medicare Advantage plans, ACOs, and provider-owned payers that need defensible, evidence-backed accuracy instead of opaque black-box probability scores, RAAPID offers a compliance-first foundation built for the V28 era.
2. Optum: Enterprise-Scale AI and Data Analytics
Optum leverages the scale and depth of the UnitedHealth Group data ecosystem to deliver risk adjustment capabilities tuned for enterprise Medicare Advantage operations and complex multi-state health plans.
Its platform combines AI-driven coding support with robust population health analytics, helping health plans surface missed diagnoses, sharpen RAF score accuracy, and generate actionable insights across extremely large member populations.
The real strength of Optum lies in the sheer volume of clinical and claims data its predictive models can process, which enables organizations to anticipate risk gaps well before they turn into lost revenue or care quality issues.
For health plans already embedded in the Optum or UnitedHealth ecosystem, the platform offers seamless workflow integration and the operational stability that comes with a vendor of its size and long tenure in the market.
3. Inovalon: Cloud-Based Predictive Analytics
Inovalon’s ONE Platform connects national-scale data access with cloud-based predictive analytics, analyzing more than 85 billion medical events across roughly 395 million unique lives.
That dataset gives Inovalon one of the largest real-world evidence repositories in the risk adjustment market, which translates into sharper risk stratification, better-prioritized interventions, and cleaner member-level insights.
The company has invested heavily in AI-powered chart review automation, including its Converged Record Review solution that can reduce unnecessary manual reviews by up to 50% for high-volume clients.
For health plans juggling large Medicare Advantage populations, Inovalon delivers meaningful operational savings without compromising the integrity of HCC capture or the quality of underlying documentation.
4. Cotiviti: Suspect Analytics and Compliance Optimization
Cotiviti has built deep expertise in risk adjustment analytics, with its Suspect Analytics solution standing out as a powerful way to surface members with potentially undocumented chronic conditions hidden across fragmented data sources.
The platform ranks suspect diagnoses by probability of confirmation, which helps health plans allocate coder time and outreach resources where they produce the highest clinical and financial return.
With the recent acquisition of Edifecs, Cotiviti has expanded its interoperability footprint and tightened the loop between risk adjustment workflows and broader health data exchange across payers and providers.
This combination positions the platform to help health plans unify fragmented source systems while staying aligned with evolving CMS compliance requirements and V28 documentation expectations.
5. Datavant (formerly Apixio): NLP-Powered Unstructured Data Extraction
Datavant, formerly known as Apixio, focuses squarely on one of the hardest problems in risk adjustment, which is extracting accurate insights from unstructured clinical documentation that sits outside coded claims data.
Its AI-powered platform uses advanced NLP to parse physician notes, discharge summaries, lab reports, and other free-text content that traditional rule-based systems routinely miss or misinterpret.
The platform supports both Medicare Advantage and ACA risk adjustment programs, with particular strength in scaling chart review across very large and clinically diverse populations.
For organizations buried under unstructured medical records, Datavant offers a targeted way to lift HCC capture rates and improve RAF score accuracy without requiring a massive internal rebuild of existing infrastructure.
What to Look for in Risk Adjustment Technology in 2026
Choosing the right platform in 2026 is a strategic decision rather than a simple technology purchase, because CMS audit enforcement and V28 implementation have raised the cost of coding errors considerably.
Explainability now matters more than ever, and any platform worth serious consideration should be able to trace every HCC back to specific MEAT evidence inside the clinical record.
End-to-end lifecycle coverage is equally important, since point solutions that handle only retrospective or only prospective workflows tend to create integration gaps, duplicated work, and operational blind spots for coding teams.
The strongest platforms connect pre-visit planning, point-of-care capture, retrospective review, and RADV audit defense inside a single source of truth for member risk and health status.
Data quality rounds out the short list of essentials because even the most advanced AI will underperform when it is fed fragmented, duplicated, or poorly normalized inputs from disconnected legacy systems.
Leading platforms harmonize structured and unstructured data across EHRs, claims, labs, and pharmacy feeds to construct a complete and reliable picture of each member’s ongoing health status and care journey.
Implementation support and the vendor partnership model also deserve scrutiny, because even the best technology will stall without proper change management, coder training, and workflow redesign assistance.
Ask for case studies from similar organizations, run a proof of concept with your own real data, and confirm that the vendor brings a dedicated customer success team rather than a transactional software relationship.
The Bottom Line
The 2026 risk adjustment technology landscape has decisively shifted from manual, reactive processes toward AI-driven platforms that capture health status with speed, precision, and defensibility baked in from day one.
Health plans that modernize now will protect legitimate revenue while building a sustainable audit posture as CMS oversight continues to intensify under the fully implemented V28 model.
Among the five platforms profiled above, RAAPID stands out for the combined strength of its Neuro-Symbolic AI engine, built-in MEAT evidence trails, and comprehensive lifecycle coverage delivered under a single roof.
Every organization has unique needs, but standing still is no longer a viable option, and the gap between intelligent risk adjustment and legacy approaches will only widen from this point forward.
For organizations evaluating their next move, the most valuable exercise is to map each platform’s capabilities against your specific RADV exposure, V28 readiness gaps, and internal coder capacity.
That alignment, rather than brand familiarity or surface-level feature lists, is what ultimately determines whether a risk adjustment investment delivers measurable returns in 2026 and beyond.
